keyword
https://read.qxmd.com/read/38297833/development-of-cns-tropic-aav1-like-variants-with-reduced-liver-targeting-following-systemic-administration-in-mice
#21
JOURNAL ARTICLE
Matthieu Drouyer, Jessica Merjane, Deborah Nazareth, Maddison Knight, Suzanne Scott, Sophia H Y Liao, Samantha L Ginn, Erhua Zhu, Ian E Alexander, Leszek Lisowski
Directed evolution of natural AAV9 using peptide display libraries have been widely used in the search for an optimal recombinant AAV (rAAV) for transgene delivery across the blood-brain barrier (BBB) to the central nervous system (CNS) following intravenous (i.v.) injection. In this study, we utilised a different approach by creating a shuffled rAAV capsid library based on parental AAV serotypes 1 through 12. Following selection in mice, three novel variants closely related to AAV1, AAV-BBB6, AAV-BBB28, and AAV-BBB31, emerged as top candidates...
January 31, 2024: Molecular Therapy
https://read.qxmd.com/read/38287297/glioblastoma-margin-as-a-diffusion-barrier-revealed-by-photoactivation-of-plasmonic-nanovesicles
#22
JOURNAL ARTICLE
Hejian Xiong, Blake A Wilson, Xiaoqian Ge, Xiaofei Gao, Qi Cai, Xueqi Xu, Robert Bachoo, Zhenpeng Qin
Glioblastoma (GBM) is the most complex and lethal primary brain cancer. Adequate drug diffusion and penetration are essential for treating GBM, but how the spatial heterogeneity in GBM impacts drug diffusion and transport is poorly understood. Herein, we report a new method, photoactivation of plasmonic nanovesicles (PANO), to measure molecular diffusion in the extracellular space of GBM. By examining three genetically engineered GBM mouse models that recapitulate key clinical features including the angiogenic core and diffuse infiltration, we found that the tumor margin has the lowest diffusion coefficient (highest tortuosity) compared with the tumor core and surrounding brain tissue...
January 29, 2024: Nano Letters
https://read.qxmd.com/read/38275376/genes-associated-with-altered-brain-structure-and-function-in-obstructive-sleep-apnea
#23
JOURNAL ARTICLE
Yijie Huang, Chong Shen, Wei Zhao, Youlan Shang, Yisong Wang, Hui-Ting Zhang, Ruoyun Ouyang, Jun Liu
Obstructive sleep apnea (OSA) has been widely reported to cause abnormalities in brain structure and function, but the genetic mechanisms behind these changes remain largely unexplored. Our research aims to investigate the relationship between sleep characteristics, cognitive impairments, genetic factors, and brain structure and function in OSA. Using structural and resting-state functional magnetic resonance imaging data, we compared cortical morphology and spontaneous brain activity between 28 patients with moderate-to-severe OSA and 34 healthy controls (HCs) utilizing voxel-based morphology (VBM) and the amplitude of low-frequency fluctuations (ALFF) analyses...
December 20, 2023: Biomedicines
https://read.qxmd.com/read/38256087/advanced-cellular-models-for-rare-disease-study-exploring-neural-muscle-and-skeletal-organoids
#24
REVIEW
Cristina Bombieri, Andrea Corsi, Elisabetta Trabetti, Alessandra Ruggiero, Giulia Marchetto, Gaetano Vattemi, Maria Teresa Valenti, Donato Zipeto, Maria Grazia Romanelli
Organoids are self-organized, three-dimensional structures derived from stem cells that can mimic the structure and physiology of human organs. Patient-specific induced pluripotent stem cells (iPSCs) and 3D organoid model systems allow cells to be analyzed in a controlled environment to simulate the characteristics of a given disease by modeling the underlying pathophysiology. The recent development of 3D cell models has offered the scientific community an exceptionally valuable tool in the study of rare diseases, overcoming the limited availability of biological samples and the limitations of animal models...
January 13, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38235404/human-stem-cell-modeling-of-neuropsychiatric-disorders-from-polygenicity-to-convergence
#25
JOURNAL ARTICLE
Jubao Duan
Neuropsychiatric disorders (NPD) are prevalent and devastating, posing an enormous socioeconomic burden to modern society. Recent genetic studies of NPD have identified a plethora of common genetic risk variants with small effect sizes and rare risk variants of high penetrance. While exciting, there is a pressing need to translate these genetic discoveries into better understanding of disease biology and more tailored clinical interventions. Human induced pluripotent stem cell (hiPSC)-derived 2D and 3D neural cultures are becoming a promising cellular model for bridging the gap between genetic findings and disease biology for NPD...
August 2023: Med Rev (2021)
https://read.qxmd.com/read/38229168/stable-neuron-specific-gene-expression-in-the-mouse-brain
#26
JOURNAL ARTICLE
Osama Ahmed, Kingsley M Ekumi, Francesco V Nardi, Gulimiheranmu Maisumu, Khaled Moussawi, Eric D Lazartigues, Bo Liang, Abraam M Yakoub
Gene delivery to, and expression in, the mouse brain is important for understanding gene functions in brain development and disease, or testing gene therapies. Here, we describe an approach to express a transgene in the mouse brain in a cell-type-specific manner. We use stereotaxic injection of a transgene-expressing adeno-associated virus into the mouse brain via the intracerebroventricular route. We demonstrate stable and sustained expression of the transgene in neurons of adult mouse brain, using a reporter gene driven by a neuron-specific promoter...
January 16, 2024: Journal of Biological Engineering
https://read.qxmd.com/read/38212785/taming-microglia-the-promise-of-engineered-microglia-in-treating-neurological-diseases
#27
REVIEW
Echo Yongqi Luo, Rio Ryohichi Sugimura
Microglia, the CNS-resident immune cells, are implicated in many neurological diseases. Nearly one in six of the world's population suffers from neurological disorders, encompassing neurodegenerative and neuroautoimmune diseases, most with dysregulated neuroinflammation involved. Activated microglia become phagocytotic and secret various immune molecules, which are mediators of the brain immune microenvironment. Given their ability to penetrate through the blood-brain barrier in the neuroinflammatory context and their close interaction with neurons and other glial cells, microglia are potential therapeutic delivery vehicles and modulators of neuronal activity...
January 11, 2024: Journal of Neuroinflammation
https://read.qxmd.com/read/38184741/genetically-engineered-hek-cells-as-a-valuable-tool-for-studying-electroporation-in-excitable-cells
#28
JOURNAL ARTICLE
Tina Batista Napotnik, Bor Kos, Tomaž Jarm, Damijan Miklavčič, Rodney P O'Connor, Lea Rems
Electric pulses used in electroporation-based treatments have been shown to affect the excitability of muscle and neuronal cells. However, understanding the interplay between electroporation and electrophysiological response of excitable cells is complex, since both ion channel gating and electroporation depend on dynamic changes in the transmembrane voltage (TMV). In this study, a genetically engineered human embryonic kidney cells expressing NaV 1.5 and Kir 2.1, a minimal complementary channels required for excitability (named S-HEK), was characterized as a simple cell model used for studying the effects of electroporation in excitable cells...
January 6, 2024: Scientific Reports
https://read.qxmd.com/read/38180686/understanding-current-experimental-models-of-glioblastoma-brain-microenvironment-interactions
#29
REVIEW
Niket Yadav, Benjamin W Purow
Glioblastoma (GBM) is a common and devastating primary brain tumor, with median survival of 16-18 months after diagnosis in the setting of substantial resistance to standard-of-care and inevitable tumor recurrence. Recent work has implicated the brain microenvironment as being critical for GBM proliferation, invasion, and resistance to treatment. GBM does not operate in isolation, with neurons, astrocytes, and multiple immune populations being implicated in GBM tumor progression and invasiveness. The goal of this review article is to provide an overview of the available in vitro, ex vivo, and in vivo experimental models for assessing GBM-brain interactions, as well as discuss each model's relative strengths and limitations...
January 5, 2024: Journal of Neuro-oncology
https://read.qxmd.com/read/38167295/engineering-paralog-specific-psd-95-recombinant-binders-as-minimally-interfering-multimodal-probes-for-advanced-imaging-techniques
#30
JOURNAL ARTICLE
Charlotte Rimbault, Christelle Breillat, Benjamin Compans, Estelle Toulmé, Filipe Nunes Vicente, Monica Fernandez-Monreal, Patrice Mascalchi, Camille Genuer, Virginia Puente-Muñoz, Isabel Gauthereau, Eric Hosy, Stéphane Claverol, Gregory Giannone, Ingrid Chamma, Cameron D Mackereth, Christel Poujol, Daniel Choquet, Matthieu Sainlos
Despite the constant advances in fluorescence imaging techniques, monitoring endogenous proteins still constitutes a major challenge in particular when considering dynamics studies or super-resolution imaging. We have recently evolved specific protein-based binders for PSD-95, the main postsynaptic scaffold proteins at excitatory synapses. Since the synthetic recombinant binders recognize epitopes not directly involved in the target protein activity, we consider them here as tools to develop endogenous PSD-95 imaging probes...
January 3, 2024: ELife
https://read.qxmd.com/read/38154956/design-of-ultrapotent-genetically-encoded-inhibitors-of-kv4-2-for-gating-neural-plasticity
#31
JOURNAL ARTICLE
Michael Andreyanov, Ronit Heinrich, Shai Berlin
The Kv4.2 potassium channel plays established roles in neuronal excitability, while also being implicated in plasticity. Current means to study the roles of Kv4.2 are limited, motivating us to design a genetically encoded membrane tethered Heteropodatoxin-2 (MetaPoda). We find that MetaPoda is an ultrapotent and selective gating-modifier of Kv4.2. We narrow its site of contact with the channel to two adjacent residues within the voltage sensitive domain (VSD) and, with docking simulations, suggest that the toxin binds the VSD from within the membrane...
December 28, 2023: Journal of Neuroscience
https://read.qxmd.com/read/38137555/preclinical-efficacy-of-peripheral-nerve-regeneration-by-schwann-cell-like-cells-differentiated-from-human-tonsil-derived-mesenchymal-stem-cells-in-c22-mice
#32
JOURNAL ARTICLE
Yu Hwa Nam, Saeyoung Park, Yoonji Yum, Soyeon Jeong, Hyo Eun Park, Ho Jin Kim, Jaeseung Lim, Byung-Ok Choi, Sung-Chul Jung
Charcot-Marie-Tooth disease (CMT) is a hereditary disease with heterogeneous phenotypes and genetic causes. CMT type 1A (CMT1A) is a type of disease affecting the peripheral nerves and is caused by the duplication of the peripheral myelin protein 22 ( PMP22 ) gene. Human tonsil-derived mesenchymal stem cells (TMSCs) are useful for stem cell therapy in various diseases and can be differentiated into Schwann cell-like cells (TMSC-SCs). We investigated the potential of TMSC-SCs called neuronal regeneration-promoting cells (NRPCs) for peripheral nerve and muscle regeneration in C22 mice, a model for CMT1A...
December 17, 2023: Biomedicines
https://read.qxmd.com/read/38137552/rodent-models-of-huntington-s-disease-an-overview
#33
REVIEW
Giulio Nittari, Proshanta Roy, Ilenia Martinelli, Vincenzo Bellitto, Daniele Tomassoni, Enea Traini, Seyed Khosrow Tayebati, Francesco Amenta
Huntington's disease (HD) is an autosomal-dominant inherited neurological disorder caused by a genetic mutation in the IT15 gene. This neurodegenerative disorder is caused by a polyglutamine repeat expansion mutation in the widely expressed huntingtin (HTT) protein. HD is characterized by the degeneration of basal ganglia neurons and progressive cell death in intrinsic neurons of the striatum, accompanied by dementia and involuntary abnormal choreiform movements. Animal models have been extensively studied and have proven to be extremely valuable for therapeutic target evaluations...
December 16, 2023: Biomedicines
https://read.qxmd.com/read/38137504/ast-001-improves-social-deficits-and-restores-dopamine-neuron-activity-in-a-mouse-model-of-autism
#34
JOURNAL ARTICLE
Ki Bum Um, Soyoung Kwak, Sun-Ha Cheon, JuHyun Kim, Su-Kyeong Hwang
Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder characterized by impaired social communication and social interaction, restricted and repetitive behavior, and interests. The core symptoms of ASD are associated with deficits in mesocorticolimbic dopamine pathways that project from the ventral tegmental area (VTA) to the nucleus accumbens (NAc) and medial prefrontal cortex (mPFC). AST-001 is an investigational product currently in a phase 3 clinical trial for treating the core symptoms of ASD, with L-serine as the API (active pharmaceutical ingredient)...
December 12, 2023: Biomedicines
https://read.qxmd.com/read/38137503/early-effects-of-alpha-synuclein-depletion-by-pan-neuronal-inactivation-of-encoding-gene-on-electroencephalogram-coherence-between-different-brain-regions-in-mice
#35
JOURNAL ARTICLE
Vasily Vorobyov, Alexander Deev, Olga Morozova, Zoya Oganesyan, Anastasia M Krayushkina, Tamara A Ivanova, Kirill Chaprov
UNLABELLED: Inactivation of the Snca gene in young mice by chronic injections of tamoxifen (TAM), a selective estrogen receptor modifier, has been shown to decrease the level of alpha-synuclein, a key peptide in the pathogenesis of Parkinson's disease. In young mice, different time courses of the effect were observed in different brain areas, meaning associated disturbances in the intracerebral relations, namely in brain function after TAM-induced synucleinopathy. METHODS: We analyzed electroencephalogram (EEG) coherence ("functional connectivity") between the cortex (MC), putamen (Pt), and dopamine-producing brain regions (ventral tegmental area, VTA, and substantia nigra, SN) in two groups of two-month-old male mice...
December 12, 2023: Biomedicines
https://read.qxmd.com/read/38111036/hla-based-banking-of-induced-pluripotent-stem-cells-in-saudi-arabia
#36
JOURNAL ARTICLE
Maryam Alowaysi, Robert Lehmann, Mohammad Al-Shehri, Moayad Baadhaim, Hajar Alzahrani, Doaa Aboalola, Asima Zia, Dalal Malibari, Mustafa Daghestani, Khaled Alghamdi, Ali Haneef, Dunia Jawdat, Fahad Hakami, David Gomez-Cabrero, Jesper Tegner, Khaled Alsayegh
BACKGROUND: Human iPSCs' derivation and use in clinical studies are transforming medicine. Yet, there is a high cost and long waiting time associated with autologous iPS-based cellular therapy, and the genetic engineering of hypo-immunogenic iPS cell lines is hampered with numerous hurdles. Therefore, it is increasingly interesting to create cell stocks based on HLA haplotype distribution in a given population. This study aimed to assess the potential of HLA-based iPS banking for the Saudi population...
December 18, 2023: Stem Cell Research & Therapy
https://read.qxmd.com/read/38096407/a-cgal-uas-bipartite-expression-toolkit-for-caenorhabditis-elegans-sensory-neurons
#37
JOURNAL ARTICLE
Stephanie Nava, Wilber Palma, Xuan Wan, Jun Young Oh, Shahla Gharib, Han Wang, Jasmin S Revanna, Minyi Tan, Mark Zhang, Jonathan Liu, Chun-Hao Chen, James S Lee, Barbara Perry, Paul W Sternberg
Animals integrate sensory information from the environment and display various behaviors in response to external stimuli. In Caenorhabditis elegans hermaphrodites, 33 types of sensory neurons are responsible for chemosensation, olfaction, and mechanosensation. However, the functional roles of all sensory neurons have not been systematically studied due to the lack of facile genetic accessibility. A bipartite cGAL-UAS system has been previously developed to study tissue- or cell-specific functions in C. elegans ...
December 19, 2023: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/38074413/anti-tau-intrabodies-from-anti-tau-immunoglobulins-to-the-development-of-functional-scfv-intrabodies
#38
JOURNAL ARTICLE
Dina Rodrigues Martins, Fern Sha, Wim Van der Elst, Pei-Yu Shih, Jens Devoght, Kristof Van Kolen, Marc Mercken, Bianca Van Broeck, Paul Declerck, Clara Theunis
Over the last decade, there has been a growing interest in intrabodies and their therapeutic potential. Intrabodies are antibody fragments that are expressed inside a cell to target intracellular antigens. In the context of intracellular protein misfolding and aggregation, such as tau pathology in Alzheimer's disease, intrabodies have become an interesting approach as there is the possibility to target early stages of aggregation. As such, we engineered three anti-tau monoclonal antibodies into single-chain variable fragments for cytoplasmic expression and activity: PT51, PT77, and hTau21...
December 14, 2023: Molecular Therapy. Methods & Clinical Development
https://read.qxmd.com/read/38069329/advancements-in-2d-and-3d-in-vitro-models-for-studying-neuromuscular-diseases
#39
REVIEW
Haneul Kim, Gon Sup Kim, Sang-Hwan Hyun, Eunhye Kim
Neuromuscular diseases (NMDs) are a genetically or clinically heterogeneous group of diseases that involve injury or dysfunction of neuromuscular tissue components, including peripheral motor neurons, skeletal muscles, and neuromuscular junctions. To study NMDs and develop potential therapies, remarkable progress has been made in generating in vitro neuromuscular models using engineering approaches to recapitulate the complex physical and biochemical microenvironments of 3D human neuromuscular tissues. In this review, we discuss recent studies focusing on the development of in vitro co-culture models of human motor neurons and skeletal muscles, with the pros and cons of each approach...
November 30, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/38012300/engineered-compact-pan-neuronal-promoter-from-alphaherpesvirus-lap2-enhances-target-gene-expression-in-the-mouse-brain-and-reduces-tropism-in-the-liver
#40
JOURNAL ARTICLE
Carola J Maturana
Small promoters capable of driving potent neuron-restricted gene expression are required to support successful brain circuitry and clinical gene therapy studies. However, converting large promoters into functional MiniPromoters, which can be used in vectors with limited capacity, remains challenging. In this study, we describe the generation of a novel version of alphaherpesvirus latency-associated promoter 2 (LAP2), which facilitates precise transgene expression exclusively in the neurons of the mouse brain while minimizing undesired targeting in peripheral tissues...
November 27, 2023: Gene Therapy
keyword
keyword
82932
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.